NR4A1 and obesity disorder: Based on a large retrospective analysis of four randomized clinical trials of operable BC patients treated with anthracyclines and taxanes, and adjusting for hormone receptor and HER2 status, we found that severe obesity, but not obesity, emerged as a statistically and clinically significant unfavorable prognostic factor regardless of BC subtype.